- Home
- ORRF vs CRMD Comparison
ORRF vs CRMD Comparison
Compare ORRF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORRF
- CRMD
- Stock Information
- Founded
- ORRF 1919
- CRMD 2006
- Country
- ORRF United States
- CRMD United States
- Employees
- ORRF N/A
- CRMD N/A
- Industry
- ORRF Major Banks
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- ORRF Finance
- CRMD Health Care
- Exchange
- ORRF Nasdaq
- CRMD Nasdaq
- Market Cap
- ORRF 779.9M
- CRMD 738.4M
- IPO Year
- ORRF N/A
- CRMD 2010
- Fundamental
- Price
- ORRF $36.42
- CRMD $12.49
- Analyst Decision
- ORRF Buy
- CRMD Strong Buy
- Analyst Count
- ORRF 4
- CRMD 6
- Target Price
- ORRF $32.00
- CRMD $15.67
- AVG Volume (30 Days)
- ORRF 99.5K
- CRMD 1.3M
- Earning Date
- ORRF 01-28-2025
- CRMD 03-11-2025
- Dividend Yield
- ORRF 2.55%
- CRMD N/A
- EPS Growth
- ORRF N/A
- CRMD N/A
- EPS
- ORRF 1.26
- CRMD N/A
- Revenue
- ORRF $148,169,000.00
- CRMD $12,262,234.00
- Revenue This Year
- ORRF N/A
- CRMD N/A
- Revenue Next Year
- ORRF $34.12
- CRMD $246.41
- P/E Ratio
- ORRF $28.52
- CRMD N/A
- Revenue Growth
- ORRF 14.06
- CRMD 41184.20
- 52 Week Low
- ORRF $24.70
- CRMD $2.89
- 52 Week High
- ORRF $41.99
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- ORRF 49.33
- CRMD 70.88
- Support Level
- ORRF $35.62
- CRMD $7.91
- Resistance Level
- ORRF $37.09
- CRMD $13.09
- Average True Range (ATR)
- ORRF 0.83
- CRMD 0.70
- MACD
- ORRF 0.18
- CRMD 0.43
- Stochastic Oscillator
- ORRF 80.16
- CRMD 88.68
About ORRF Orrstown Financial Services Inc
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time and savings deposits, and granting loans. It is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending. Deposit services include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based, account maintenance, and overdraft services, it also earns wealth management and investment brokerage fees from its contracts with trust. The company operates in a significant segment - Community Banking.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.